drugset / Trial / NCT00391846
Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose is to study if HF treatment guided by NTproBNP in addition to clinical symptoms and signs is more effective than treatment guided by clinical symptoms and signs alone in patients with HF and left ventricular systolic dysfunction
Timeline
- Start
- 2006-10
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Bisoprolol | Other / unclassified | — | — |
| Background | Candesartan | Unknown | — | — |
| Background | Captopril | Small molecule | — | — |
| Background | Carvedilol | Other / unclassified | — | — |
| Background | Enalapril | Other / unclassified | — | — |
| Background | Eplerenone | Unknown | — | — |
| Background | LISINOPRIL ANHYDROUS | Small molecule | — | — |
| Background | Metoprolol | Other / unclassified | — | — |
| Background | Ramipril | Small molecule | — | — |
| Background | Spironolactone | Small molecule | — | — |
| Background | Valsartan | Unknown | — | — |
| Background | trandolapril | Small molecule | — | — |